Abstract
Morbid obesity is considered a civilization disease of the 21st century. Not only does obesity increase mortality, but it is also the most important cause of the shortening life expectancy in the modern world. Obesity is associated with many metabolic abnormalities: dyslipidemia, hyperglycemia, cardiovascular diseases, and others. An increasing number of patients diagnosed with chronic kidney disease (CKD) are obese. Numerous additional disorders associated with impaired kidney function make it difficult to conduct slimming therapy and may also be associated with a greater number of complications than in people with normal kidney function. Currently available treatments for obesity include lifestyle modification, pharmacotherapy, and bariatric surgery (BS). There are no precise recommendations on how to reduce excess body weight in patients with CKD treated conservatively, undergoing chronic dialysis, or after kidney transplantation. The aim of this study was to analyze studies on the bariatric treatment of obesity in this group of people, as well as to compare the recommendations typical for bariatrics and CKD.
Subject
Food Science,Nutrition and Dietetics
Reference122 articles.
1. WHO (2022, November 08). Obesity and Overweight. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. The economic impact of obesity in the United States;Hammond;Diabetes Metab. Syndr. Obes.,2010
3. The physical and fi scal impact of the obesity epidemic: The impact of comorbid conditions on patients and payers;Bhoyrul;J. Manag. Care Med.,2008
4. Multiorgan insulin sensitivity in lean and obese subjects;Conte;Diabetes Care,2012
5. Benefits and Risks of Bariatric Surgery in Adults: A Review;Arterburn;JAMA,2020
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献